Clicky

bioAffinity Technologies, Inc.(BIAF)

Description: bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.


Keywords: Biotechnology Cancer Life Sciences Biology Lung Cancer Diagnostic Tests Molecular Diagnostics Cancer Therapeutics Rosetta Genomics

Home Page: www.bioaffinitytech.com

BIAF Technical Analysis

22211 West Interstate 10
San Antonio, TX 78257
United States
Phone: 210 698 5334


Officers

Name Title
Ms. Maria Zannes J.D. Founder, Pres, CEO & Director
Dr. Vivienne I. Rebel M.D., Ph.D. Exec. VP and Chief Medical & Science Officer
Mr. Michael Edwards CPA, M.B.A. Chief Financial Officer
Mr. Xavier T. Reveles M.S. VP of Operations
Mr. Timothy P. Zannes J.D. Exec. VP, Sec. & Gen. Counsel
Dr. William Bauta Ph.D. Sr. VP of Therapeutics

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.3353
Price-to-Sales TTM: 6847.0483
IPO Date: 2022-09-01
Fiscal Year End: December
Full Time Employees: 11
Back to stocks